Maki Tanioka

Proteogenomic integration reveals therapeutic targets in breast cancer xenografts

Kuan‐lin Huang, Shunqiang Li, Philipp Mertins et al. · Nature Communications · 2017 · 153 citations · Full text

Integrated Analysis of RNA and DNA from the Phase III Trial CALGB 40601 Identifies Predictors of Response to Trastuzumab-Based Neoadjuvant Chemotherapy in HER2-Positive Breast Cancer

Maki Tanioka, Joel S. Parker, Katherine A. Hoadley et al. · Clinical Cancer Research · 2018 · 87 citations · Full text

Phase I study of LY2181308, an antisense oligonucleotide against survivin, in patients with advanced solid tumors

Maki Tanioka, Hiroshi Nokihara, Noboru Yamamoto et al. · Cancer Chemotherapy and Pharmacology · 2010 · 82 citations

Oncology, Medicine, Oligonucleotide +11

Applicability of the concept of “platinum sensitivity” to recurrent endometrial cancer: The SGSG-012/GOTIC-004/Intergroup study

Shoji Nagao, Shin Nishio, Hirofumi Michimae et al. · Gynecologic Oncology · 2013 · 75 citations

Sgsg-012/gotic-004/intergroup Study, Medicine, Cancer Management +7

A Phase I, dose‐finding and pharmacokinetic study of olaparib (AZD2281) in Japanese patients with advanced solid tumors*,†

Noboru Yamamoto, Hiroshi Nokihara, Yasuhide Yamada et al. · Cancer Science · 2011 · 75 citations · Full text

Breast Oncology, Cancer Management, Pharmacokinetic Study +17